NO20084124L - Sammensetninger og fremgangsmater for fluid vevsokning - Google Patents

Sammensetninger og fremgangsmater for fluid vevsokning

Info

Publication number
NO20084124L
NO20084124L NO20084124A NO20084124A NO20084124L NO 20084124 L NO20084124 L NO 20084124L NO 20084124 A NO20084124 A NO 20084124A NO 20084124 A NO20084124 A NO 20084124A NO 20084124 L NO20084124 L NO 20084124L
Authority
NO
Norway
Prior art keywords
compositions
methods
tissue suction
fluid tissue
hydrogel
Prior art date
Application number
NO20084124A
Other languages
English (en)
Norwegian (no)
Inventor
Nathaniel E David
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Publication of NO20084124L publication Critical patent/NO20084124L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO20084124A 2006-03-13 2008-09-29 Sammensetninger og fremgangsmater for fluid vevsokning NO20084124L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/276,759 US20070212385A1 (en) 2006-03-13 2006-03-13 Fluidic Tissue Augmentation Compositions and Methods
PCT/US2007/006258 WO2007106457A2 (en) 2006-03-13 2007-03-12 Fluidic tissue augmentation compositions and methods

Publications (1)

Publication Number Publication Date
NO20084124L true NO20084124L (no) 2008-12-03

Family

ID=38479221

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084124A NO20084124L (no) 2006-03-13 2008-09-29 Sammensetninger og fremgangsmater for fluid vevsokning

Country Status (11)

Country Link
US (4) US20070212385A1 (zh)
EP (1) EP1996137A4 (zh)
JP (1) JP2009529965A (zh)
KR (1) KR20080109774A (zh)
CN (1) CN101400327A (zh)
AU (1) AU2007225196A1 (zh)
BR (1) BRPI0708872A2 (zh)
CA (1) CA2644561A1 (zh)
EA (1) EA200870352A1 (zh)
NO (1) NO20084124L (zh)
WO (1) WO2007106457A2 (zh)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
US20080293637A1 (en) 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
AU2008282922B2 (en) 2007-07-27 2014-01-16 Humacyte, Inc. Compositions comprising human collagen and human elastin and methods for soft tissue augmentation
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
US20090204101A1 (en) * 2007-08-20 2009-08-13 Wortzman Mitchell S Method of applying an injectable filler
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8709395B2 (en) 2007-10-29 2014-04-29 Ayman Boutros Method for repairing or replacing damaged tissue
US7910134B2 (en) * 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8475815B2 (en) * 2007-10-29 2013-07-02 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8431141B2 (en) * 2007-10-29 2013-04-30 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
WO2009059121A1 (en) * 2007-11-02 2009-05-07 Genzyme Corporation Methods of augmenting or repairing soft tissue
SI2818184T1 (sl) 2007-11-16 2019-03-29 Aclaris Therapeutics, Inc. Sestava in postopki za zdravljenje purpure
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
CA2719254C (en) 2008-03-27 2019-04-30 Purdue Research Foundation Collagen-binding synthetic peptidoglycans, preparation, and methods of use
GB2459438B (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Systems and methods for transdermal photo-polymerization
WO2009158145A2 (en) * 2008-05-30 2009-12-30 Allergan, Inc. Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form
US20110182957A1 (en) * 2008-06-19 2011-07-28 Nicoll Steven B Cellulosics for tissue replacement
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
EP3184552B1 (en) 2008-09-02 2020-08-12 Tautona Group LP Threads of hyaluronic acid, methods of making thereof and uses thereof
WO2010027471A2 (en) 2008-09-04 2010-03-11 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
CN102164580A (zh) * 2008-09-16 2011-08-24 恩伟绅技术公司 可分解的生物相容水凝胶及使用其的系统和方法
US9193948B2 (en) 2008-11-12 2015-11-24 The Trustees Of The University Of Pennsylvania Biomaterials for tissue replacement
BRPI0922629A2 (pt) * 2008-12-02 2016-01-05 Allergan Inc dispositivo de injeção
CA2762212C (en) * 2009-05-20 2015-12-29 Humacyte, Inc. Elastin for soft tissue augmentation
US20110137260A1 (en) 2009-12-07 2011-06-09 Allergan, Inc. Slotted syringe
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
WO2011109730A2 (en) 2010-03-04 2011-09-09 The General Hospital Corporation Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production
JP5749283B2 (ja) 2010-03-12 2015-07-15 アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｉｎｄｕｓｔｒｉｅ Ｓａｓ 皮膚状態を改善するための流体組成物
DK3078388T3 (da) 2010-03-22 2019-05-20 Allergan Inc Tværbundne hydrogeler til blødvævsforøgelse
US8815228B2 (en) 2010-04-30 2014-08-26 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
EP2756857B1 (en) 2010-05-19 2016-05-18 Allergan, Inc. Modular injection device
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
GB201014388D0 (en) * 2010-08-31 2010-10-13 Fujifilm Mfg Europe Bv Biocompatible compositions for tissue augmentation
US20130217789A1 (en) * 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
US20120130490A1 (en) * 2010-09-24 2012-05-24 Dominique Erni Method for reconstruction and augmentation of the breast
WO2012085835A2 (fr) 2010-12-20 2012-06-28 L'oreal Composition liquide et stérile pour le comblement des rides
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
KR102006036B1 (ko) 2011-05-24 2019-07-31 시믹 아이피, 엘엘씨 히알루론산-결합 합성 펩티도글리칸 및 이의 제조 및 이용 방법
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
CN107412002A (zh) 2011-06-03 2017-12-01 阿勒根公司 包括抗氧化剂的皮肤填充剂组合物
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
CN102321248B (zh) * 2011-06-10 2013-04-24 冯淑芹 一种用于填充与修复受损组织的可注射温敏凝胶
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US9272079B2 (en) * 2011-10-13 2016-03-01 Kci Licensing, Inc. Stimulation of cartilage formation using reduced pressure treatment
US8603028B2 (en) 2011-11-18 2013-12-10 Allergan, Inc. Injection device having an angled tip portion
KR101269423B1 (ko) * 2011-12-22 2013-05-30 오스템임플란트 주식회사 체내 분해 속도 조절이 가능한 수화젤 및 그 제조 방법
WO2014028463A1 (en) 2012-08-14 2014-02-20 Allergan, Inc. Syringe for mixing and dispensing adipose tissue
US9220807B2 (en) 2012-11-04 2015-12-29 Miba Medical Inc. Non-toxic cross-linker for hyaluronic acid
EP2962680A4 (en) * 2013-02-28 2016-12-28 Amorepacific Corp COMPOSITION FOR MAINTAINING THE EFFICIENCY OF A LOAD
AU2014233537A1 (en) 2013-03-15 2015-09-10 Symic Ip, Llc Extracellular matrix-binding synthetic peptidoglycans
WO2014169299A1 (en) * 2013-04-12 2014-10-16 Bui The Duy Temperature-release catalyst for cross-linking halyuronic acid during injection
US20150190517A1 (en) * 2013-04-12 2015-07-09 Miba Medical Inc. Systems and methods for delivering cross-linked halyuronic acid into a patient
US9744260B2 (en) 2013-04-12 2017-08-29 Phi Nguyen Timing controlled in-situ cross-linking of halyuronic acid during injection
US20140350518A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
JP7004501B2 (ja) * 2013-12-03 2022-01-21 コーネル ユニバーシティー 線維輪を修復する方法及びコラーゲンゲル組成物
KR20150110332A (ko) 2014-03-20 2015-10-02 (주)아모레퍼시픽 필러의 효능 유지용 조성물
WO2015141978A1 (ko) * 2014-03-20 2015-09-24 (주)아모레퍼시픽 필러의 효능 유지용 조성물
KR102365648B1 (ko) * 2014-04-14 2022-02-21 아키나, 인크. 신규한 하이드로겔 조직 확장제
WO2015164822A1 (en) 2014-04-25 2015-10-29 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US9561095B1 (en) * 2015-10-12 2017-02-07 Phi Nguyen Body augmentation device
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
BR112017000813B1 (pt) 2014-07-17 2021-03-16 The Regents Of The University Of California sistemas de gel microporoso, usos de uma pluralidade de partículas de microgel em uma solução aquosa e um agente de recozimento, de camadas de sequestrantes covalentemente estabilizados de partículas de microgel, e de um sequestrante covalentemente estabilizado de partículas de microgel com espaços intersticiais, bem como método para a preparação de partículas de microgel
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
US10226585B2 (en) 2014-10-01 2019-03-12 Allergan, Inc. Devices for injection and dosing
US9439983B1 (en) 2014-10-24 2016-09-13 Verily Life Sciences Llc Method for integrating nanoparticles as part of a hydrogel matrix
TWI716365B (zh) * 2014-11-13 2021-01-21 德商梅茲製藥有限兩合公司 注射型真皮填充劑組合物及其套組、製備方法、與使用
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
CA2976544A1 (en) 2015-03-10 2016-09-15 Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company Multiple needle injector
CN104940998A (zh) * 2015-06-08 2015-09-30 苏州乔纳森新材料科技有限公司 一种软组织填充材料及其制备方法
WO2017042301A1 (en) * 2015-09-09 2017-03-16 ETH Zürich Injectable macroporous hydrogels
JP2018531065A (ja) * 2015-10-02 2018-10-25 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 多チャンバシリンジユニットおよび多チャンバシリンジを作製する方法
US20170103184A1 (en) * 2015-10-12 2017-04-13 Phi Nguyen Injectable filler
US10112119B2 (en) * 2015-11-09 2018-10-30 Disney Enterprises, Inc. Method for modifying local properties of materials
US11931480B2 (en) 2016-02-16 2024-03-19 The Regents Of The University Of California Microporous annealed particle gels and methods of use
KR102232054B1 (ko) 2016-04-08 2021-03-26 알레간 인코포레이티드 흡인 및 주입 디바이스
KR101710639B1 (ko) * 2016-06-07 2017-03-08 주식회사 파마리서치프로덕트 핵산, 키토산 및 히알루론산을 포함하는 조직 증강용 충전 조성물 및 이의 제조방법
KR20180035032A (ko) * 2016-09-28 2018-04-05 주식회사 파마리서치프로덕트 가교 히알루론산을 포함하는 주사용 조성물
AU2017394923B2 (en) 2016-12-29 2022-07-14 Tempo Therapeutics, Inc. Methods and systems for treating a site of a medical implant
USD867582S1 (en) 2017-03-24 2019-11-19 Allergan, Inc. Syringe device
US20180368394A1 (en) * 2017-06-27 2018-12-27 Inteli-Straw, LLC Semen/gamete and embryo storage receptacles with rfid data identification
CN110809478A (zh) 2017-07-07 2020-02-18 斯米克Ip有限公司 合成的生物缀合物
WO2019088656A1 (ko) 2017-11-02 2019-05-09 주식회사 엑소코바이오 안정화된 엑소좀의 필러 조성물
KR20190051434A (ko) 2017-11-07 2019-05-15 주식회사 엑소코바이오 신규한 히알루론산 기반의 필러 조성물 및 이의 응용
CN109651625A (zh) * 2018-12-17 2019-04-19 北京理工大学 一种高强度丙烯酰胺-羧甲基纤维素双网络结构水凝胶灭火垫的制备方法
CN110575564B (zh) * 2019-09-30 2020-05-08 张勇 用于医学整形美容的填充物及其制备方法和应用
US20230263943A1 (en) * 2020-04-29 2023-08-24 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels for in situ-forming tissue constructs
WO2022031073A1 (ko) * 2020-08-06 2022-02-10 주식회사 삼양홀딩스 수화겔 형성용 조성물, 이를 광가교시켜 형성된 수화겔 및 그 수화겔 제조방법
CN114680443B (zh) * 2020-12-31 2024-10-15 常州柚盾实业投资有限公司 一种去衍生给药装置及其应用、包含该装置的护肤品
EP4395796A1 (en) 2021-09-01 2024-07-10 Shanghai Qisheng Biological Preparation Co., Ltd. Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells
CN114146021A (zh) * 2021-12-31 2022-03-08 北京清美联创干细胞科技有限公司 一种含表皮生长因子的化妆品组合物及其制备方法
KR102673797B1 (ko) * 2023-03-28 2024-06-10 주식회사 파마리서치바이오 핵산 및 칼슘 하이드록실아파타이트를 포함하는 필러 조성물

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380536A (en) * 1978-04-06 1983-04-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing para-amino-benzoic acid-N-D-mannoside as an active ingredient
US4645969A (en) * 1980-08-01 1987-02-24 General Electric Company Skin tanning fluorescent lamp construction utilizing a phosphor combination
US5024742A (en) * 1988-02-24 1991-06-18 Cedars-Sinai Medical Center Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) * 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
US5380536A (en) * 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
EP0696185B1 (en) * 1993-04-28 1998-08-12 Focal, Inc. Apparatus, product and use related to intraluminal photothermoforming
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US5964749A (en) * 1995-09-15 1999-10-12 Esc Medical Systems Ltd. Method and apparatus for skin rejuvenation and wrinkle smoothing
US7883693B2 (en) * 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US5902599A (en) * 1996-02-20 1999-05-11 Massachusetts Institute Of Technology Biodegradable polymer networks for use in orthopedic and dental applications
US6106514A (en) * 1996-08-12 2000-08-22 O'donnell, Jr.; Francis E. Laser method for subsurface cutaneous treatment
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US6050990A (en) * 1996-12-05 2000-04-18 Thermolase Corporation Methods and devices for inhibiting hair growth and related skin treatments
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US6165205A (en) * 1998-07-10 2000-12-26 Ceramoptec Industries, Inc. Method for improved wound healing
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6231613B1 (en) * 1998-12-15 2001-05-15 Enteric Medical Technologies, Inc. Methods for soft tissue augmentation in mammals
US6858229B1 (en) * 1999-04-26 2005-02-22 California Institute Of Technology In situ forming hydrogels
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US20020128695A1 (en) * 1999-07-07 2002-09-12 Yoram Harth Apparatus and method for high energy photodynamic therapy of acne vulgaris and seborrhea
US20020088131A1 (en) * 1999-10-08 2002-07-11 Baxa Ronald Dale Syringe dose identification system
US6699470B1 (en) * 1999-10-12 2004-03-02 Massachusetts Institute Of Technology Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation
DE69920236T2 (de) * 1999-11-29 2005-09-29 Mectron S.R.L., Carasco Zahnärztliches Handstück zur Fotopolymerisation kompatibel zu der Energieversorgungseinrichtung von anderen Handstücken
US6527764B1 (en) * 1999-12-02 2003-03-04 Ceramoptec Industries, Inc. Device and method for laser biomodulation in PDT/surgery
US7097855B1 (en) * 2000-01-31 2006-08-29 Massachusetts Institute Of Technology Transdermal thermal polymerization
US7160931B2 (en) * 2000-03-15 2007-01-09 Yu-Ling Cheng Thermally reversible implant and filler
EP2269645A3 (en) * 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US6602275B1 (en) * 2000-09-18 2003-08-05 Jana Sullivan Device and method for therapeutic treatment of living organisms
AU2002252025A1 (en) * 2001-02-23 2002-09-12 University Of Massachusetts Injection molding of living tissues
US20030009158A1 (en) * 2001-07-09 2003-01-09 Perricone Nicholas V. Skin treatments using blue and violet light
US6835064B2 (en) * 2001-11-09 2004-12-28 Ivoclar Vivadent Ag Light hardening device and method for hardening a polymerizable mass for dental applications
EP1314402B1 (en) * 2001-11-22 2005-06-29 Mectron S.R.L. Optical system for a dental Handpiece for polymerization of photosetting compounds or resins
US6843967B2 (en) * 2002-04-11 2005-01-18 Pentron Laboratory Technologies, Llc Curing unit
US7113950B2 (en) * 2002-06-27 2006-09-26 Microsoft Corporation Automated error checking system and method
US8673333B2 (en) * 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
US7862831B2 (en) * 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20050069572A1 (en) * 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
JP2004284820A (ja) * 2002-12-10 2004-10-14 Inventio Ag エレベータケージのケージドアとケージ壁との間のギャップの密閉デバイス
WO2004075984A1 (en) * 2003-02-26 2004-09-10 Photo Therapeutics Ltd. Therapeutic method and apparatus
US7637900B2 (en) * 2003-03-13 2009-12-29 Cheryl Burgess Methods of administering a material into a patient for dermal enhancement
US20060222677A1 (en) * 2004-01-14 2006-10-05 Bianca Baroli Method of protecting sensitive molecules from a photo-polymerizing environment
ES2546393T3 (es) * 2004-04-20 2015-09-23 Genzyme Corporation Implante quirúrgico tipo malla
WO2006002050A1 (en) * 2004-06-15 2006-01-05 Encore Therapeutics, Inc. Phospholipid compositions and methods for their preparation and use
EP1796690A4 (en) * 2004-09-22 2011-08-03 Cartilix Inc KNORPELFÜLLVORRICHTUNG
US7414021B2 (en) * 2004-10-01 2008-08-19 Vincent Carmine Giampapa Method and composition for restoration of age related tissue loss in the face or selected areas of the body
CA2585215A1 (en) * 2004-10-28 2006-05-11 Surmodics, Inc. Pro-fibrotic coatings comprising collagen for medical implants
TW200633723A (en) * 2005-01-27 2006-10-01 Corium Int Inc Hydrophilic biocompatible adhesive formulations and uses
US7321004B2 (en) * 2005-02-11 2008-01-22 New Photonics, Llc Method for photo-curing polymerizable compositions
US20060188940A1 (en) * 2005-02-22 2006-08-24 Michael Cima Combinatorial hydrogel formulation
CA2611693A1 (en) * 2005-06-15 2006-12-28 Surmodics, Inc. Macromer composition including light activated initiator
US20070003584A1 (en) * 2005-06-16 2007-01-04 Russell Anderson Liquid crystal polymer syringes and containers and methods of use for long term storage of filler materials
US20070122392A1 (en) * 2005-06-22 2007-05-31 Sharon Gerecht-Nir Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel
US7521434B2 (en) * 2005-06-27 2009-04-21 Luromed Llc Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them
US8999933B2 (en) * 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
TWI291417B (en) * 2006-08-10 2007-12-21 Hi Touch Imaging Tech Co Ltd Printer having a printhead with fixed angle
WO2009059121A1 (en) * 2007-11-02 2009-05-07 Genzyme Corporation Methods of augmenting or repairing soft tissue
GB2459438B (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Systems and methods for transdermal photo-polymerization

Also Published As

Publication number Publication date
US20080038306A1 (en) 2008-02-14
CA2644561A1 (en) 2007-09-20
WO2007106457A2 (en) 2007-09-20
JP2009529965A (ja) 2009-08-27
EP1996137A2 (en) 2008-12-03
WO2007106457A3 (en) 2007-11-29
US20110087152A1 (en) 2011-04-14
KR20080109774A (ko) 2008-12-17
US20160279288A1 (en) 2016-09-29
EP1996137A4 (en) 2012-06-20
US20070212385A1 (en) 2007-09-13
CN101400327A (zh) 2009-04-01
EA200870352A1 (ru) 2009-04-28
AU2007225196A1 (en) 2007-09-20
BRPI0708872A2 (pt) 2011-06-14

Similar Documents

Publication Publication Date Title
NO20084124L (no) Sammensetninger og fremgangsmater for fluid vevsokning
WO2008005873A3 (en) Methods, systems and apparatus for relieving pressure in an organ
WO2007087536A3 (en) Retraction apparatus and method of use
WO2007089864A3 (en) Sutures and fibrosing agents
WO2011034627A3 (en) Methods and apparatus for introducing cells at a tissue site
WO2008039269A3 (en) Method and apparatus for performing an open wedge, high tibial osteotomy
WO2009067245A3 (en) Compositions and methods for tissue repair
WO2006138669A3 (en) Life-like anatomic feature for testing injection of soft tissue fillers
WO2008112912A3 (en) Internal fixation devices
EP2319548A3 (en) Tissue scaffolds
WO2006058215A3 (en) In situ method for treatment and repair of meniscal injuries
CL2008003305A1 (es) Composicion inyectable que comprende un agente activo seleccionado de un grupo definido; al menos un polimero bioerosionable, al menos un solvente no toxico y opcionalmente uno o mas excipientes; proceso de preparacion; uso para tratar enfermedades mentales o cancer.
JP2007517543A5 (zh)
SE0200207L (sv) Kedjeförlängd dendritisk polyeter
EP2656823A3 (en) Ophthalmic surgical device for capsulotomy
DE602005026556D1 (de) Zusammensetzung zur proteasomhemmung
BRPI0718146A2 (pt) Dispositivos de infusão e métodos
BRPI0701080A2 (pt) conjunto de cateterizaÇço trans-sÉptica e mÉtodos
WO2007081896A3 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
WO2008083174A3 (en) Compositions and methods for the treatment of infections and tumors
NO20085187L (no) Anordning ved sugefundament
WO2006042149A3 (en) Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
CR10227A (es) Sal de ácido succínico del éster 1-[2-(2-cloro-4-{[(R)-2-hidroxi-2-(8-hidroxi-2-oxo-1,2-dihidroquinolin-5-il)etilmino]metil}-5-metoxifenilcarbamoil)etil]piperidin-4-ílicodelácidobifenil2ilcarbámicoysuusoparaeltratamientodetrastornospulmonar
WO2011050344A3 (en) Cancer immunotherapy and method of treatment
WO2008044068A8 (en) Combination therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application